- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
SeQuent Scientific Limited has announced a board meeting approving key management changes. Ms. Revati Parag Kasture will be appointed as a Non-executive Independent Director starting December 17, 2024, for five years, pending shareholder approval. Mr. Phillip Trott has stepped down as Company Secretary and Compliance Officer, effective the same day but will remain with the company in other capacities. Ms. Yoshita Vora will assume the role of Company Secretary and Compliance Officer on December 17, 2024.
These leadership changes may enhance the company's governance structure. The appointment of Kasture, with her extensive experience in ratings, aligns with SeQuent's strategic focus. This could create a positive outlook among investors, given the fresh expertise introduced to the board.